INCY
$88.90
Incyte
$.96
1.09%
INCY
Earnings Whisper ®
N/A
4th Quarter December 2019
Consensus:  $0.54
Revenue:  $569.75 Mil
Tuesday
Jan 28
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when INCY reports earnings?
Beat
Meet
Miss

Where is INCY's stock price going from here?
Up
Flat
Down
Stock chart of INCY
Analysts
Summary of analysts' recommendations for INCY
Score
Grade
Pivots
Resistance
$89.50
$89.07
$88.50

$88.07

Support
$87.50
$87.07
$86.50
Tweet
Growth
Description
Incyte Corp is a drug discovery company that is using its expertise in genomics, medicinal chemistry and molecular, cellular and in vivo biology to discover and develop novel therapeutics. The company has three fully-staffed drug discovery programs underway focused primarily on the identification of new small molecule drugs for cancer and inflammation. Incyte also has strategic alliances with Lexicon Genetics and Medarex focused on the discovery and development of protein therapeutics or antibodies to treat inflammatory diseases and cancer.
Peers
Alexion PharmaceuticalsExact SciencesCharles River Laboratories InternationalExelixisCoherus BiosciencesLuminex